Septerna, Inc. Common Stock (NASDAQ:SEPN) — Market Cap & Net Worth
Market Cap & Net Worth: Septerna, Inc. Common Stock (SEPN)
Septerna, Inc. Common Stock (NASDAQ:SEPN) has a market capitalization of $1.23 Billion ($1.23 Billion) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8171 globally and #2334 in its home market, demonstrating a 15.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Septerna, Inc. Common Stock's stock price $35.80 by its total outstanding shares 44774192 (44.77 Million). Review SEPN total liabilities to assess the company's total debt and financial obligations.
Septerna, Inc. Common Stock Market Cap History: 2024 to 2026
Septerna, Inc. Common Stock's market capitalization history from 2024 to 2026. Data shows growth from $1.03 Billion to $1.60 Billion (51.83% CAGR).
Index Memberships
Septerna, Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.05% | #228 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #871 of 3165 |
Weight: Septerna, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Septerna, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Septerna, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
953.79x
Septerna, Inc. Common Stock's market cap is 953.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.03 Billion | $1.07 Million | -$71.80 Million | 953.79x | N/A |
Competitor Companies of SEPN by Market Capitalization
Companies near Septerna, Inc. Common Stock in the global market cap rankings as of June 18, 2026.
Key companies related to Septerna, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $458.99 |
| #444 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.63 Billion | $607.93 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €252.40 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €780.20 |
Septerna, Inc. Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Septerna, Inc. Common Stock's market cap moved from $1.03 Billion to $ 1.60 Billion, with a yearly change of 51.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.60 Billion | +28.41% |
| 2025 | $1.25 Billion | +21.75% |
| 2024 | $1.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Septerna, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.23 Billion USD |
| MoneyControl | $1.23 Billion USD |
| MarketWatch | $1.23 Billion USD |
| marketcap.company | $1.23 Billion USD |
| Reuters | $1.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Septerna, Inc. Common Stock
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 … Read more